Economic Impact of a Preferred Anti-Methicillin Susceptible Staphylococcus aureus Protocol

Clin Infect Dis. 2018 Apr 17;66(9):1483-1484. doi: 10.1093/cid/cix1072.

Authors

Timothy P Gauthier¹, Mara Carrasquillo¹, Paola Lichtenberger^{2

3}, Gio Baracco^{2

3}

Affiliations

¹ Department of Pharmacy, University of Miami Miller School of Medicine, Florida.
² Department of Infectious Diseases, Miami Veterans Affairs Healthcare System, University of Miami Miller School of Medicine, Florida.
³ Department of Medicine, Division of Infectious Diseases, University of Miami Miller School of Medicine, Florida.

PMID: 29211820
DOI: 10.1093/cid/cix1072

No abstract available

Publication types

Comment

MeSH terms

Bacteremia*
Cefazolin
Cohort Studies
Humans
Methicillin
Nafcillin
Oxacillin
Staphylococcus aureus*

Substances

Nafcillin
Cefazolin
Methicillin
Oxacillin